IBDEI15E ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,18637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18637,1,3,0)
;;=3^Rheumatic Mitral Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,18637,1,4,0)
;;=4^I05.9
;;^UTILITY(U,$J,358.3,18637,2)
;;=^5007044
;;^UTILITY(U,$J,358.3,18638,0)
;;=I21.3^^64^833^87
;;^UTILITY(U,$J,358.3,18638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18638,1,3,0)
;;=3^STEMI Myocardial Infarction,Unspec Site
;;^UTILITY(U,$J,358.3,18638,1,4,0)
;;=4^I21.3
;;^UTILITY(U,$J,358.3,18638,2)
;;=^5007087
;;^UTILITY(U,$J,358.3,18639,0)
;;=I44.30^^64^833^49
;;^UTILITY(U,$J,358.3,18639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18639,1,3,0)
;;=3^Atrioventricular Block,Unspec
;;^UTILITY(U,$J,358.3,18639,1,4,0)
;;=4^I44.30
;;^UTILITY(U,$J,358.3,18639,2)
;;=^5007204
;;^UTILITY(U,$J,358.3,18640,0)
;;=I50.40^^64^833^58
;;^UTILITY(U,$J,358.3,18640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18640,1,3,0)
;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
;;^UTILITY(U,$J,358.3,18640,1,4,0)
;;=4^I50.40
;;^UTILITY(U,$J,358.3,18640,2)
;;=^5007247
;;^UTILITY(U,$J,358.3,18641,0)
;;=I50.30^^64^833^59
;;^UTILITY(U,$J,358.3,18641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18641,1,3,0)
;;=3^Diastolic Congestive Hrt Failure,Unspec
;;^UTILITY(U,$J,358.3,18641,1,4,0)
;;=4^I50.30
;;^UTILITY(U,$J,358.3,18641,2)
;;=^5007243
;;^UTILITY(U,$J,358.3,18642,0)
;;=I50.20^^64^833^88
;;^UTILITY(U,$J,358.3,18642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18642,1,3,0)
;;=3^Systolic Congestive Hrt Failure,Unspec
;;^UTILITY(U,$J,358.3,18642,1,4,0)
;;=4^I50.20
;;^UTILITY(U,$J,358.3,18642,2)
;;=^5007239
;;^UTILITY(U,$J,358.3,18643,0)
;;=I20.0^^64^833^89
;;^UTILITY(U,$J,358.3,18643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18643,1,3,0)
;;=3^Unstable Angina
;;^UTILITY(U,$J,358.3,18643,1,4,0)
;;=4^I20.0
;;^UTILITY(U,$J,358.3,18643,2)
;;=^5007076
;;^UTILITY(U,$J,358.3,18644,0)
;;=M32.12^^64^833^80
;;^UTILITY(U,$J,358.3,18644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18644,1,3,0)
;;=3^Pericarditis in Systemic Lupus Erythematosus
;;^UTILITY(U,$J,358.3,18644,1,4,0)
;;=4^M32.12
;;^UTILITY(U,$J,358.3,18644,2)
;;=^5011755
;;^UTILITY(U,$J,358.3,18645,0)
;;=I50.811^^64^833^3
;;^UTILITY(U,$J,358.3,18645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18645,1,3,0)
;;=3^AC Right Heart Failure
;;^UTILITY(U,$J,358.3,18645,1,4,0)
;;=4^I50.811
;;^UTILITY(U,$J,358.3,18645,2)
;;=^5151385
;;^UTILITY(U,$J,358.3,18646,0)
;;=I50.813^^64^833^7
;;^UTILITY(U,$J,358.3,18646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18646,1,3,0)
;;=3^AC on Chr Right Heart Failure
;;^UTILITY(U,$J,358.3,18646,1,4,0)
;;=4^I50.813
;;^UTILITY(U,$J,358.3,18646,2)
;;=^5151387
;;^UTILITY(U,$J,358.3,18647,0)
;;=I50.812^^64^833^56
;;^UTILITY(U,$J,358.3,18647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18647,1,3,0)
;;=3^Chr Right Heart Failure
;;^UTILITY(U,$J,358.3,18647,1,4,0)
;;=4^I50.812
;;^UTILITY(U,$J,358.3,18647,2)
;;=^5151386
;;^UTILITY(U,$J,358.3,18648,0)
;;=I50.84^^64^833^61
;;^UTILITY(U,$J,358.3,18648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18648,1,3,0)
;;=3^End Stage Heart Failure
;;^UTILITY(U,$J,358.3,18648,1,4,0)
;;=4^I50.84
;;^UTILITY(U,$J,358.3,18648,2)
;;=^5151391
;;^UTILITY(U,$J,358.3,18649,0)
;;=I50.810^^64^833^66
;;^UTILITY(U,$J,358.3,18649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18649,1,3,0)
;;=3^Heart Failure,Right,Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI15E 3814 printed Oct 16, 2024@18:02:54 Page 2
IBDEI15E ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,18637,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,18637,1,3,0)
+4 ;;=3^Rheumatic Mitral Valve Disease,Unspec
+5 ;;^UTILITY(U,$J,358.3,18637,1,4,0)
+6 ;;=4^I05.9
+7 ;;^UTILITY(U,$J,358.3,18637,2)
+8 ;;=^5007044
+9 ;;^UTILITY(U,$J,358.3,18638,0)
+10 ;;=I21.3^^64^833^87
+11 ;;^UTILITY(U,$J,358.3,18638,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,18638,1,3,0)
+14 ;;=3^STEMI Myocardial Infarction,Unspec Site
+15 ;;^UTILITY(U,$J,358.3,18638,1,4,0)
+16 ;;=4^I21.3
+17 ;;^UTILITY(U,$J,358.3,18638,2)
+18 ;;=^5007087
+19 ;;^UTILITY(U,$J,358.3,18639,0)
+20 ;;=I44.30^^64^833^49
+21 ;;^UTILITY(U,$J,358.3,18639,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,18639,1,3,0)
+24 ;;=3^Atrioventricular Block,Unspec
+25 ;;^UTILITY(U,$J,358.3,18639,1,4,0)
+26 ;;=4^I44.30
+27 ;;^UTILITY(U,$J,358.3,18639,2)
+28 ;;=^5007204
+29 ;;^UTILITY(U,$J,358.3,18640,0)
+30 ;;=I50.40^^64^833^58
+31 ;;^UTILITY(U,$J,358.3,18640,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,18640,1,3,0)
+34 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
+35 ;;^UTILITY(U,$J,358.3,18640,1,4,0)
+36 ;;=4^I50.40
+37 ;;^UTILITY(U,$J,358.3,18640,2)
+38 ;;=^5007247
+39 ;;^UTILITY(U,$J,358.3,18641,0)
+40 ;;=I50.30^^64^833^59
+41 ;;^UTILITY(U,$J,358.3,18641,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,18641,1,3,0)
+44 ;;=3^Diastolic Congestive Hrt Failure,Unspec
+45 ;;^UTILITY(U,$J,358.3,18641,1,4,0)
+46 ;;=4^I50.30
+47 ;;^UTILITY(U,$J,358.3,18641,2)
+48 ;;=^5007243
+49 ;;^UTILITY(U,$J,358.3,18642,0)
+50 ;;=I50.20^^64^833^88
+51 ;;^UTILITY(U,$J,358.3,18642,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,18642,1,3,0)
+54 ;;=3^Systolic Congestive Hrt Failure,Unspec
+55 ;;^UTILITY(U,$J,358.3,18642,1,4,0)
+56 ;;=4^I50.20
+57 ;;^UTILITY(U,$J,358.3,18642,2)
+58 ;;=^5007239
+59 ;;^UTILITY(U,$J,358.3,18643,0)
+60 ;;=I20.0^^64^833^89
+61 ;;^UTILITY(U,$J,358.3,18643,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,18643,1,3,0)
+64 ;;=3^Unstable Angina
+65 ;;^UTILITY(U,$J,358.3,18643,1,4,0)
+66 ;;=4^I20.0
+67 ;;^UTILITY(U,$J,358.3,18643,2)
+68 ;;=^5007076
+69 ;;^UTILITY(U,$J,358.3,18644,0)
+70 ;;=M32.12^^64^833^80
+71 ;;^UTILITY(U,$J,358.3,18644,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,18644,1,3,0)
+74 ;;=3^Pericarditis in Systemic Lupus Erythematosus
+75 ;;^UTILITY(U,$J,358.3,18644,1,4,0)
+76 ;;=4^M32.12
+77 ;;^UTILITY(U,$J,358.3,18644,2)
+78 ;;=^5011755
+79 ;;^UTILITY(U,$J,358.3,18645,0)
+80 ;;=I50.811^^64^833^3
+81 ;;^UTILITY(U,$J,358.3,18645,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,18645,1,3,0)
+84 ;;=3^AC Right Heart Failure
+85 ;;^UTILITY(U,$J,358.3,18645,1,4,0)
+86 ;;=4^I50.811
+87 ;;^UTILITY(U,$J,358.3,18645,2)
+88 ;;=^5151385
+89 ;;^UTILITY(U,$J,358.3,18646,0)
+90 ;;=I50.813^^64^833^7
+91 ;;^UTILITY(U,$J,358.3,18646,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,18646,1,3,0)
+94 ;;=3^AC on Chr Right Heart Failure
+95 ;;^UTILITY(U,$J,358.3,18646,1,4,0)
+96 ;;=4^I50.813
+97 ;;^UTILITY(U,$J,358.3,18646,2)
+98 ;;=^5151387
+99 ;;^UTILITY(U,$J,358.3,18647,0)
+100 ;;=I50.812^^64^833^56
+101 ;;^UTILITY(U,$J,358.3,18647,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,18647,1,3,0)
+104 ;;=3^Chr Right Heart Failure
+105 ;;^UTILITY(U,$J,358.3,18647,1,4,0)
+106 ;;=4^I50.812
+107 ;;^UTILITY(U,$J,358.3,18647,2)
+108 ;;=^5151386
+109 ;;^UTILITY(U,$J,358.3,18648,0)
+110 ;;=I50.84^^64^833^61
+111 ;;^UTILITY(U,$J,358.3,18648,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,18648,1,3,0)
+114 ;;=3^End Stage Heart Failure
+115 ;;^UTILITY(U,$J,358.3,18648,1,4,0)
+116 ;;=4^I50.84
+117 ;;^UTILITY(U,$J,358.3,18648,2)
+118 ;;=^5151391
+119 ;;^UTILITY(U,$J,358.3,18649,0)
+120 ;;=I50.810^^64^833^66
+121 ;;^UTILITY(U,$J,358.3,18649,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,18649,1,3,0)
+124 ;;=3^Heart Failure,Right,Unspec
